Indian indices closed lower Tuesday, with investors cautious ahead of the US Federal Reserve’s rate decision. Vedanta, ITC, and Piramal Pharma saw notable price action. Analysts suggest Vedanta and ITC are good long-term buys, while Piramal Pharma shows potential for further upside after a recent correction.
Looking for top-performing equity mutual funds? Here are the best performers across categories in the last 1 year
Returns from mutual fund schemes over the past year show a wide gap between the best- and worst-performing funds across categories, underscoring the importance of
August 1, 2026